Published: January 2024 | Report Code: 12838 | Available Format: PDF
The global intubation tubes market is valued at an estimated USD 2,727.6 million in 2023, which is expected to reach USD 4,294.4 million by 2030, growing at a CAGR of 6.9% during 2024–2030.
The significant increase in the count of surgeries and incidence of chronic diseases, including cancer, cardiac diseases, and respiratory illnesses, is the biggest factor driving the growth of the market. Moreover, the growing awareness regarding the adoption of single-use intubation tubes can help stem the surge in the cases of healthcare-associated infections, such as ventilator-associated pneumonia (VAP).
A frequent occurrence of VAP is usually observed in patients who have been intubated for over two days. A significantly higher number of VAP cases are reported in Europe than in North America. It is one of the most-common hospital-acquired infections and responsible for a high mortality rate. This reason has led to significant technological enhancements in these devices. To this effect, many companies are working on anticoagulation and antibacterial coatings to prevent infections through the tube.
For instance, in April 2020, Hydromer Incorporated was announced as the exclusive manufacturing partner as well as coating provider for N8 Medical’s CeraShield coated endotracheal tubes. CeraShield endotracheal tube has been granted Emergency Use Access marketing approval for all Canadian mechanically ventilated coronavirus patients by Health Canada. In addition, notwithstanding the risk of VAP, the process of intubation is quite common and safe, and it can help in saving the patient’s life.
Additionally, the increasing hospitalization rates and technological developments in the sector would propel the industry expansion. Respiratory conditions, including asthma, pulmonary hypertension, and chronic obstructive pulmonary disease, are increasing significantly in prevalence. This can be ascribed to the adoption of sedentary lifestyles, which involve smoking, lack of physical activity, and other unhealthy habits.
Among these, COPD is one of the most-prominent causes of mortality among individuals globally. Additionally, mortality due to lung ailments is significantly influenced by age. Prolonged exposure to industry smoke, dust, harmful chemicals, and fumes increases the chances of the development of such diseases. Therefore, the requirement for intubation during the treatment of the above-mentioned disease is driving the market growth.
The coronavirus outbreak had a significant positive impact on the intubation tubes market. There was a rapid rise in the number of severely ill patients, for whom intubation was required in emergencies, as one of the major issues that came along with the disease was difficulty in breathing. These tubes are an accepted way of providing breathing support to patients suffering from the novel coronavirus. According to the Association for Bronchology and Interventional Pulmonology, coronavirus patients who are suffering from respiratory distress or failure need to undergo percutaneous dilatational tracheostomy or open surgical tracheostomy (OST). Therefore, this outbreak opened up a new opportunity for the sector by hastening the product approvals for emergency use.
Over the years, there has been a significant surge in the number of road accidents resulting in death. The WHO reports that approximately 1.5 million individuals lose their lives in road accidents each year. A considerable economic loss and emotional trauma to victims’ families are the additional burdens that come along with such mishaps. Major accidents result in significant trauma to patients, who then require immediate treatment or surgical intervention, thereby increasing the demand for intubation tubes.
Market Size in 2023
USD 2,727.6 Million
Market Size in 2024
USD 2,878.5 Million
Revenue Forecast in 2030
USD 4,294.4 Million
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
By Product; By Route; By Application; By End User; By Region
Explore more about this report - Request free sample
The regular category dominates the market, with a share of 40%, in 2023. This is because of the surge in the volume of surgical procedures owing to the rise in the prevalence of respiratory illnesses. Moreover, the increasing prevalence of VAP is expected to boost the requirement of technologically advanced tubes significantly.
The reinforced category is expected to witness a high growth rate during the forecast period. This is attributable to the rising number of patients with neurological conditions requiring surgeries and the surging number of road accidents and facial surgeries.
These tubes are increasingly being used in neurosurgeries for remote airway access. Here, these variants offer advantages over regular ones by resisting twisting and compression, due to their structural design, as they consist of a metal coil, which is generally made of stainless steel and spirally wound in the wall of the tube. Therefore, the significant rise in the incidence of neurological disorders and awareness regarding its early treatment are propelling the industrial expansion.
A positive impact on the usage of these tubes is also being observed due to the tremendous surge in the volume of cosmetic procedures, especially in the facial region. This is because people are becoming increasingly self-conscious of their appearance and adopting the path of cosmetic surgery to boost their self-esteem and confidence.
The orotracheal category leads the market, with a share of around 75%, in 2023. This is because this is the most-common route of insertion of these tubes owing to its comfort for patients. In addition, it is widely used in the treatment of apneic as well as critically ill patients ailing from severe injuries and multisystem diseases. Moreover, in cases requiring immediate medical intervention, such as heart attacks, airway obstruction, and hypoxia, intensivists utilize the orotracheal route for tube insertion.
Additionally, respiratory illnesses, such as COPD and asthma, which continue to rise in prevalence, require the insertion of an intubation tube through the nasotracheal route, which would significantly propel the nasotracheal category during the forecast period. The usage of these tubes allows for the delivery of anesthetic gases without restricting access to intraoral anatomy. This is why this approach is also used in surgical procedures for diseases other than those of the respiratory system, such as maxillofacial, dental, and oropharyngeal operations. Moreover, the widening applicability of these tubes in emergency situations, including cardiopulmonary arrest and severe injuries, is a key contributor to this category’s growth.
The emergency treatment category leads the market, with a share of around 55%, in 2023. This is credited to the rising prevalence of emergencies such as accidents, cardiopulmonary arrest, obstruction of the airways, and respiratory distress.
In addition, the therapy category is expected to grow at a significant rate during the projected period. This is credited to the rising number of surgical procedures, most of which require intubation tubes for the management of the airways. Apart from the spiking chronic respiratory ailment prevalence and surging occurrence of fatal injuries due to road accidents, the rising disposable personal income in emerging economies is a major market driver in this category.
North America accounts for the largest share, of around 60%, in 2023. This is credited to the well-established reimbursement policies, strong healthcare infrastructure and services, and increasing adoption of technologically enhanced equipment by the medical sector in the region. Furthermore, the rising need to provide quality patient care, surging prevalence of chronic diseases, such as asthma and cancer, and presence of top players are the key contributors.
There has been a significant rise in the number of cancer cases in the North American region of late. The American Cancer Society estimated 1.9 million new cancer diagnoses and 609,360 deaths due to it in the U.S. in 2022. This rise in the cancer burden can be attributed to the increasing consumption of alcohol and high-calorie food, resulting in obesity; and smoking. Many cancer patients, especially those suffering from lung cancer, suffer from breathing difficulties, which is why they need to be intubated for long periods.
Furthermore, the surge in the prevalence of allergic reactions, including anaphylaxis, and the rising awareness among patients of receiving quality care in such cases are the key contributors.
In addition, Europe is expected to hold the second-largest share, with the market growth here majorly attributed to the rising aging population. Germany dominates the sector in the European region due to the growing prevalence of communicable diseases and the presence of a large number of skilled medical professionals.
Additionally, the increasing healthcare spending, advancing medical facilities, and rising awareness among people regarding early disease diagnosis will propel the market expansion in the U.K. during the forecast period.
This fully customizable report gives a detailed analysis of the intubation tubes market from 2017 to 2030, based on all the relevant segments and geographies.
Based on Product
Based on Route
Based on Route
Based on End User
In 2030, the market for intubation tubes will value USD 4,294.4 million.
The intubation tubes industry is witnessing a CAGR of 6.9%.
Reinforced tubes and those with anticoagulant and antimicrobial coatings are trending in the market for intubation tubes.
The COVID-19 pandemic has been one of the biggest intubation tubes industry growth drivers.
Product meant for orotracheal insertion generate the highest revenue in the market for intubation tubes.
The intubation tubes industry is dominated by emergency treatment applications.
North America is the largest market for intubation tubes, and APAC is growing the fastest.
Get a bespoke market intelligence solution
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws